12:17 PM EST - Nuvo Research Inc. : announced that it has completed its acquisition of ZARS Pharma, Inc. The transaction was announced on April 18, 2011. Under the terms of the acquisition agreement, Nuvo issued approximately 99.8 million common shares and paid approximately $0.1 million to the shareholders of ZARS, representing approximately 19.2% of Nuvo's shares after giving effect to the acquisition and assumed net debt of approximately $2.0 million U.S. Nuvo Research Inc.
shares T.NRI are trading up $0.01 at $0.12.
